// App-Quantinova.ai

1349 : TROCEPT mediated in-tumor delivery of immune checkpoint inhibitors reduces systemic toxicity risks and boosts immune activation

Researchers

Presenter

  • David Cole

Principal Investigators

  • Rahul Khanolkar

  • James Davies

  • Alexander Baker

  • Thomas Webb

  • Alicia Teijeira Crespo

  • Hanni Uusi-Kerttula

  • Lucy Williams

  • Samantha Moore

  • Johanne Pentier

  • Bent Jakobsen

  • Alan Parker

  • Jez Gerry

Medical Centers

  • Accession Therapeutics LTD, Oxford, UK

  • Cardiff University, Cardiff, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved